COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237

Dr Sumita Shankar

sum713@yahoo.com

2020-05-01

Recruiting

RCT

Randomized

Parallel

Not reported

multi-center

Treatment

All patients laboratory tested COVID-19 positive above 18 years of age +/- two days of admission

Known allergy to povidone iodine or iodine <br/ >thyroid disorders <br/ >pregnancy <br/ >patients on Lithium therapy <br/ >patients on respiratory distress / unconscious / on ventilator

2

WIN MEDICARE PVTLTD

18

None

India

No restriction on type of patients

0: No restriction on type of patients

96

comparing the reduction in the progression; transmission of disease in 48 participants taking oropharyngeal gargles and intranasal application of PVP-I in comparison to the control group not doing the same for which patients in both the group will be tested for viral load on 7 th and 21 st day. Spread of the disease can be checked by confirming if the nasal / oropharyngeryngel swabs turn negative and no contacts turn covid-19 positiveTimepoint: The study group will be tested for covid-19 to check for negativity on & 7th and 21st day following intervention

| Declared number of arm (2.0) differs from found arms (3.0)

Not reported

[{"arm_notes": "Used as oropharyngeal gargle and intranasal application", "treatment_id": 1015, "treatment_name": "Povidone-iodine", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]